Evidence map›Paper›PMID 30150428›Full record

ArticleIn vivo (Athens, Greece)

Characterisation of a Mouse Model of Breast Cancer with Metabolic Syndrome.

Linda A Buss, Anishah Mandani, Elisabeth Phillips, Nicola J A Scott, Margaret J Currie, Gabi U Dachs

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in In vivo (Athens, Greece). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Inhibition of APOE potentiates immune checkpoint therapy for cancer.International journal of biological sciences · 2022
    Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Linda A BussMackenzie Cancer Research Group, Department of Pathology, University of Otago, Christchurch, New Zealand.
Anishah MandaniMackenzie Cancer Research Group, Department of Pathology, University of Otago, Christchurch, New Zealand.
Elisabeth PhillipsMackenzie Cancer Research Group, Department of Pathology, University of Otago, Christchurch, New Zealand.
Nicola J A ScottChristchurch Heart Institute, Department of Medicine, University of Otago, Christchurch, New Zealand.
Margaret J CurrieMackenzie Cancer Research Group, Department of Pathology, University of Otago, Christchurch, New Zealand.
Gabi U DachsMackenzie Cancer Research Group, Department of Pathology, University of Otago, Christchurch, New Zealand gabi.dachs@otago.ac.nz.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

aimPatients with breast cancer and metabolic syndrome have poorer outcomes. We aimed to develop and characterise an apolipoprotein E-null/aromatase knockout (ApoE MATERIALS AND

methodsWild-type, ApoE

resultsTumours from ApoE

conclusionThe ApoE

Indexed as

Disease Models, AnimalAnimalsApolipoproteins EAromataseBiomarkersBreast NeoplasmsFemaleHypoxiaImmunohistochemistryMetabolic SyndromeMiceMice, KnockoutApolipoproteins EAromataseBiomarkersApoEArKObreast cancerhyperlipidaemiaMetabolic syndrome

Identifiers

PMID30150428
PMCPMC6199598

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.